DNA-free recombinant SV40 capsids protect mice from acute renal failure by inducing stress response, survival pathway and apoptotic arrest.

PloS One
Veronika Butin-IsraeliAriella Oppenheim

Abstract

Viruses induce signaling and host defense during infection. Employing these natural trigger mechanisms to combat organ or tissue failure is hampered by harmful effects of most viruses. Here we demonstrate that SV40 empty capsids (Virus Like Particles-VLPs), with no DNA, induce host Hsp/c70 and Akt-1 survival pathways, key players in cellular survival mechanisms. We postulated that this signaling might protect against organ damage in vivo. Acute kidney injury (AKI) was chosen as target. AKI is critical, prevalent disorder in humans, caused by nephrotoxic agents, sepsis or ischemia, via apoptosis/necrosis of renal tubular cells, with high morbidity and mortality. Systemic administration of VLPs activated Akt-1 and upregulated Hsp/c70 in vivo. Experiments in mercury-induced AKI mouse model demonstrated that apoptosis, oxidative stress and toxic renal failure were significantly attenuated by pretreatment with capsids prior to the mercury insult. Survival rate increased from 12% to >60%, with wide dose response. This study demonstrates that SV40 VLPs, devoid of DNA, may potentially be used as prophylactic agent for AKI. We anticipate that these finding may be projected to a wide range of organ failure, using empty capsids of SV40 as...Continue Reading

References

Jan 1, 1983·Molecular and Cellular Biology·E W Khandjian, H Türler
Dec 31, 1997·The American Journal of Medicine·P A McCulloughW W O'Neill
Nov 28, 2002·Current Opinion in Critical Care·Samuel N HeymanJoseph V Bonventre
Nov 1, 1964·Virology·P H BLACKL V CRAWFORD
Oct 31, 2003·Cancer Cell·Ji LuoLewis C Cantley
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Rinaldo BellomoUNKNOWN Acute Dialysis Quality Initiative workgroup
Nov 17, 2004·Current Pharmaceutical Biotechnology·Chava Kimchi-Sarfaty, Michael M Gottesman
Mar 23, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Christoph Aufricht
May 25, 2005·Contributions to Nephrology·Katherine J Kelly
Jul 26, 2005·Cell Stress & Chaperones·Daniel R Ciocca, Stuart K Calderwood
Aug 18, 2005·JAMA : the Journal of the American Medical Association·Shigehiko UchinoUNKNOWN Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
Sep 10, 2005·Human Gene Therapy·Chava Kimchi-SarfatyMichael M Gottesman
Sep 24, 2005·Journal of the American Society of Nephrology : JASN·Glenn M ChertowDavid W Bates
Feb 21, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Peter McCullough
Feb 25, 2006·Cell·Mark Marsh, Ari Helenius
Apr 28, 2006·Journal of Virology·Laura R ChromyRobert L Garcea
Jun 10, 2006·Critical Care Medicine·Michele MeschiGiorgio Savazzi
Jun 28, 2006·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Alessandra StacchiottiLuigi Fabrizio Rodella
Aug 25, 2006·Journal of the American Society of Nephrology : JASN·Steven D WeisbordPaul M Palevsky
Aug 26, 2006·Nature Clinical Practice. Nephrology·Michael RiordanNorman J Siegel
Feb 13, 2007·Current Opinion in Nephrology and Hypertension·Christopher Y LuJianlin Chen
Jul 3, 2007·Cell·Brendan D Manning, Lewis C Cantley
Aug 2, 2007·American Journal of Physiology. Endocrinology and Metabolism·Xiping XinSubrata Chakrabarti
Aug 23, 2007·PloS One·Santanu MukherjeeAriella Oppenheim
Feb 11, 2012·Critical Care : the Official Journal of the Critical Care Forum·Mitra K NadimUNKNOWN ADQI Workgroup

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
confocal microscopy

Software Mentioned

Photoshop
Adobe Photoshop

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis